Company / Current Liabilities
Avidity Biosciences, Inc. Current Liabilities History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$195.4M
FY2025
5-year range
$29.7M / $195.4M
FY2021-FY2025
Trend
+99.4%
vs FY2024
Sector context
#62 of 213
Health Care
What the data says
At $195M, Avidity Biosciences, Inc.'s current liabilities ranks #152 of 213 in the Health Care sector. Current Liabilities has increased for 6 consecutive years, from $10M in FY2019 to $195M in FY2025.
Based on SEC 10-K filings.
$195M in FY2025 with a 5-year CAGR of +68.0%.
Increased from $81M to $195M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +55.6%
- 5-Year CAGR
- +68.0%
- 10-Year CAGR
- -
Sector benchmark
#152 of 213 in Health CareTop 71% of 213This company $195.4M Sector average $1.6B
▼
-87.7% below sector average
Key checks
Key Insights
- Avidity Biosciences, Inc.'s current liabilities has grown for 6 consecutive years.
- 5-year CAGR of +68.0%, indicating consistent growth.
- In FY2025, current liabilities increased 99.4% year-over-year.
- Ranks #62 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $195.4M | +99.4% |
| FY2024 | $98.0M | +21.5% |
| FY2023 | $80.7M | +55.4% |
| FY2022 | $51.9M | +75.0% |
| FY2021 | $29.7M | +103.3% |
| FY2020 | $14.6M | +42.5% |
| FY2019 | $10.2M | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026